Navigation Links
Pakistan introduces vaccine to prevent top child killer
Date:10/31/2008

This month, Pakistan is introducing a new combination vaccine that will protect its children against the bacterium Haemophilus influenzae type b (Hib) and four other common childhood diseases.

Hib, a bacterium that can cause deadly meningitis and pneumonia, is one of the top killers of young children in the developing world. Even with treatment, an estimated 23,000 children die of Hib disease in Pakistan every year. Survivors are often permanently disabledparalyzed, deafened or brain damaged. Globally, over 1,000 children under 5 years of age die from Hib-related diseases each day.

"This is excellent news for generations of Pakistani children and their families. Pakistan is the largest country to date of all developing countries to introduce Hib vaccine into their national immunization program," said Dr. Rana Hajjeh, Director of the Hib Initiative. "The government's decision to introduce Hib-containing pentavalent vaccine will protect millions of infants against some of the most dangerous childhood infections, including one of the major causes of pneumonia and meningitis."

Hib is estimated to cause about 20 percent of life-threatening pneumonia cases, and it is the most common cause of life-threatening meningitis in children under 5 years of age both worldwide and in Pakistan. According to UNICEF and WHO, two million children die from pneumonia every year, making it the top child killer worldwide. Ninety-two thousand of child pneumonia deaths occur in Pakistan alone.

Although health indicators are steadily improving in Pakistan, the nation is still far from achieving its child health-related Millennium Development Goal (MDG) targets by 2015. 1 in 10 children still do not survive their fifth birthday. Most child deaths are due to pneumonia, diarrhea, and other vaccine-preventable diseases. "The introduction of the pentavalent vaccine represents a major stride toward enabling Pakistan's 160 million inhabitants to make furthe
'/>"/>

Contact: Rose Reis
rreis@jhsph.edu
410-502-4283
Johns Hopkins University Bloomberg School of Public Health
Source:Eurekalert

Page: 1 2

Related medicine news :

1. July 28, 2008: Status of Unlawfully Expelled Ahmadi Medical Students in Pakistan Still Unclear
2. Natural Nutrition Begins Exports of InterACTIVE Nutrition Brand Products to Pakistan
3. IDC implements DR systems in eight A-Class military hospitals in Pakistan
4. How to increase the chances of remaining virus free Pakistani patients with HCV?
5. USAID Launches a $60 Million Child-Spacing and Reproductive-Health Program in Pakistan
6. Siemens Introduces Life, an Open Fit Hearing Instrument That is Beautiful, Smart, and Discreet
7. Lifestyle Foods Introduces Two New Healthy Snack Options
8. BiomagScience Introduces Breakthrough Health Therapy Kits
9. Philips Introduces New, Advanced Light Therapy Device to Offer Quick Relief from Winter Blues
10. Texcel Introduces Innovative Programmable, Implantable Stimulation System for R&D of Specialty Stimulation Therapies
11. Purina(R) Pro Plan(R) Introduces Innovative Blend of Tender and Hard Kibbles

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... myEMRchoice.com Enables Pers... Fort Washington, PA (PRWEB)...ce to give consumers is to read their own medical ...(PHR), keeping control of personal medical records...ington, PA based healthcare technology company has...
(Date:12/2/2009)... Award-winning author James A...length book, Short White Coat: Lessons from Patien... through the third year of medical school--the gru...ILADELPHIA, PA (PRWEB) December 2, 2009 -- Most p...themselves dressed in a tiny hospital gown or star...
(Date:12/2/2009)... Leading medical device softw...ware has received ISO 13485 certification. A relat...ulting firms have actually achieved ISO 13485 cert...85 certification and adhere to other ISO standards...al device software engineering consulting firm to ...
(Date:12/2/2009)... , SAN DIEGO, Dec. 2 /PRNewswire-FirstCall/ ...esent at the 21st Annual Piper Jaffray Health Care...resentation is scheduled to be webcast live and ma...ion of Gen-Probe,s website at www.gen-probe.com ....ng the event. ,, About Gen-Probe ,, Gen-P...
(Date:12/2/2009)... , CHICAGO, Dec. 2 A randomiz...ve therapy to a minimally invasive treatment calle...iated disc revealed that while both treatments hel...on kept patients pain free up to two years later. ...presented today at the annual meeting of the Radio...
Breaking Medicine News(10 mins):Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3
...re-FirstCall/ -- Xi,an 38 Fule,Health & Advisory, ...oday,announced that the Company has begun trading ... symbol XNFHF. OTCQX provides a premier trading,qu...closure., "As a member of OTCQX, we look forward ...
...ronic, Inc., one of,the world,s leading developers...ced today that its MOSAIC eCO2 system, the next ge...g fractional technology with the deep,ablative fea...ontoured scanner hand piece with adjustable contro...
...ormance Program Continues to Take Root ...ay 30 Independence Blue Cross (IBC) and,Holy Rede...ced that they,have reached agreement on new contra... three years to January 1, 2011., "We,ve enjoyed ...
...TORONTO, May 30 /PRNewswire-FirstCall/ - Predictiv...) today announced it has been notified by,the Amer...continue to,support PreMD,s plan for regaining com...ion with the Securities and Exchange,Commission (t...
...y, Presentations at http://www.sto-online.org , ...ology,(STO) is pleased to announce the launch of i...uable video presentations for practicing,oncologis... American Society of Clinical Oncology (ASCO), bei...
...e less likely than white women to receive the radi...ry for early breast cancer, according to a study t...present at the annual meeting of the American Soci... breast cancer patients may be undertreated follow...
Other Medicine News:Health News:Xi'an 38 Fule Health & Advisory, LTD Lists on International OTCQX 2Health News:Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use 2Health News:Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use 3Health News:IBC Signs New Agreements with Holy Redeemer Health System 2Health News:IBC Signs New Agreements with Holy Redeemer Health System 3Health News:Delisting Notification Received from the American Stock Exchange 2Health News:Society for Translational Oncology Launches Updated Website 2Health News:Blacks, Hispanics less likely than whites to receive follow-up radiation for early breast cancer 2
(Date:12/2/2009)..., NEW YORK, Dec. 2 Kery...announced that the U.S. Food and Drug Administrati...X-0401 (perifosine), the Company,s novel, potentia...hibits the phosphoinositide 3-kinase (PI3K)/Akt pa...ltiple myeloma. ,, The Fast Track program of ...
(Date:12/2/2009)...BIRMINGHAM, Ala., Dec. 2 Adults ...osed with cancer. For adults 65 and over, the odds...ds of a man developing prostate cancer are one in ...re one in nine. Vision loss threatens the overall...injuries, depression and inability to complete dai...
(Date:12/2/2009)..., ALISO VIEJO, Calif., Dec. 2 /PRNewswire-FirstCal...echnology and services resource for pathologists, ... announced a Chief Financial Officer transition pl...ael R. Rodriguez to become its Senior Vice Preside.... Raymond J. Land, age 64, the current Senior Vice...
Breaking Medicine Technology:Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2Clarient Announces CFO Transition Plan 2Clarient Announces CFO Transition Plan 3Clarient Announces CFO Transition Plan 4Researchers at Boston University School of Medicine incorporate multisite geriatric clerkship 58687 1Researchers at Boston University School of Medicine incorporate multisite geriatric clerkship 58687 2Natural killer cells keep immune system in balance 10226 1Natural killer cells keep immune system in balance 10226 2Genetic conflict in fish led to evolution of new sex chromosomes 10224 1Genetic conflict in fish led to evolution of new sex chromosomes 10224 2
...Time, Newsweek,and U.S. World and News are all buz...earchers have found compelling evidence that these...ve and immune health, but Eastern,Europeans have b...und in,fermented foods such as yogurt, for centuri...obiotic benefits, Russian scientists have been awa...
...diac Toxicity With Equivalent Co... Cell Therapeutics, Inc.,(CTI) (Nasdaq and MTAX: ...ts phase II/III randomized study comparing CPOP-R ...with aggressive non-Hodgkin,s lymphoma,(NHL) showe...s severe,(grade 3/4) toxicities including severe i...
Other Medicine Technology:Are Muramyl Peptides the Magic Bullet in Probiotics? 2Are Muramyl Peptides the Magic Bullet in Probiotics? 3Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 2Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 3Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 4Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 5
2005 Edition of Geriatrics At Your Fingertips (PDA Version)
...Consultant, PDA Edition is designed for all physic...tic imaging studies. It provides speedy access via...t will help to determine whether imaging examinati...udies will generate the most information. The cont...
KR-8800 Auto Kerato-Refractometer
Medical Student's PDA Reference
Medicine Products: